+1 (202) 780-3397
2020: Volume 0, Issue 0
Editorial P.1-1
Market Analysis on Clinical Microbiology 2021
Author(s): Andrea Borns,
DOI: 10.35841/clinicalmicrobiology.2.S3.1-1
Short Communication P.2-2
Immunity or tissue damage to virus infections-What decides the outcome?
Author(s): Barry T. Rouse
DOI: 10.35841/Clinicalmicrobiology.2. S3.2-2
Short Communication P.3-3
Epigenetics role in cancer with considerations for regulatory reform
Author(s): Jorma A Jyrkkanen
DOI: 10.35841/Clinicalmicrobiology.2.S3.3-3
Short Communication P.4-4
Ruthenium antimicrobial compounds: a novel treatment for multi-drug resistant infections
Author(s): Kristy Laura Smitten
DOI: 10.35841/Clinicalmicrobiology.2.S3.4-4
Short Communication P.5-5
Integrative Genomic Analysis of Schizophrenia in the Basal Ganglia, and the Frontal lobe
Author(s): Pranshi Agrawal
DOI: 10.35841/Clinicalmicrobiology.2.S3.5-5
Short Communication P.6-6
Clinical Data In Chemical Biology
Author(s): Wen Wang
DOI: 10.35841/clinicalMicrobilogy.2.S3.6-6
Editorial P.1-1
Conference Announcement on Sports medicin 2021
Author(s): Dr. Sushant Sud
DOI: 10.35841/public- health.2.1.1-1
Short Communication P.2-2
Data Sustainability as a Framework for Justice in Health Data
Author(s): Dr. David Koepsell
DOI: 10.35841/public- health.2.1.2-2
Short Communication P.3-3
Ayurved apparition towards deterrence and management of nicotine addiction w.s.r to Oral health and hygiene
Author(s): Dr Sushant Sud
DOI: 10.35841/public- health.2.1.3-3
Editorial P.1-1
Drug Delivery 2021 Conferenc Announcement
Author(s): Anna Kaczmarska
DOI: 10.35841/ J Clin Path Lab Med.2.S2.1-1
Short Communication P.2-2
The Role of Gap Junctions in Disease and Potential Treatment Approaches
Author(s): Dale W Laird
DOI: 10.35841/ J Clin Path Lab Med.2.S2.2-2
Short Communication P.3-3
Development of Nano Particle Drug Delivery System for Naproxen for the Treatment of Rheumatoid Arthritis
Author(s): A Krishna Sailaja
DOI: 10.35841/ J Clin Path Lab Med.2.S2.3-3
Short Communication P.4-4
Formulation Development of Silver Nanoparticulate Drug Delivery System for the Treatment of Colorectal Cancer
Author(s): Deepa MK
DOI: 10.35841/ J Clin Path Lab Med.2.S2.4-4
Short Communication P.5-5
Apoptosis and Anti-Tumor Studies of Premna Coriacea in Breast Cancer Cell Lines and in Vivo Animal Models
Author(s): Karthikeyan M
DOI: 10.35841/ J Clin Path Lab Med.2.S2.5-5
Short Communication P.6-6
A DNA-Based Nano Carrier for Efficient Cancer Therapy
Author(s): Muhammad Abbas
DOI: 10.35841/ J Clin Path Lab Med.2.S2.6-6
Editorial P.1-1
Market Analysis on Euro Clinical Microbiology 2021
Author(s): Mohammad Moradi
DOI: 10.37532/microbial biotechnology.2.S4.1-1
Short Communication P.2-2
Influence of Proximate and Chemical Components of Kitchen Waste, Palm Kernel Waste, and Cow Dung on Electricity Generation in Microbial Fuel Cells (MFCs).
Author(s): Adebule, Adeniyi Philip
DOI: 10.37532/microbial biotechnology.2.S4.2-2
Short Communication P.3-3
Biosurfactants: A multi-approach tool in problem solving
Author(s): Oluwabusola O. Fatade
DOI: 10.37532/microbial biotechnology.2.S4.3-3
Short Communication P.4-4
Antimicrobial peptides in mycobacterial therapy
Author(s): Farzaneh Mohammadzadeh Rostami
DOI: 10.37532/microbial biotechnology.2.S4.4-4
Short Communication P.5-5
extremophilic bacterium with high potential for applications
Author(s): Mohammad Moradi
DOI: 10.37532/microbial biotechnology.2.S4.5-5
Short Communication P.5-5
Deinococcus radiodurans: an extremophilic bacterium with high potential for applications in biotechnology
Author(s): Mohammad Moradi
DOI: 10.37532/microbial biotechnology.2.S4.5-5
Short Communication P.6-6
FUNCTIONAL FOODS: AN INNOVATIVE PROGRESSSION FOR BIOINDUSTRIES
Author(s): Nivedita Sharma
DOI: 10.37532/microbial biotechnology.2.S4.6-6
Short Communication P.7-7
CRISPR technology and its impact on microbial biotechnology
Author(s): Sajjad Yazdanpanah
DOI: 10.37532/microbial biotechnology.2.S4.7-7
Editorial P.1-1
Young Researcher Award for Euro clinical microbiology 2021
Author(s): Nivedita Sharma
DOI: 10.37532/clinicalmicrobiology.2.S3.1-1
Short Communication P.2-2
oxidoreductases probably causes resistance in gram negative bacteria
Author(s): Malihe Mohamadkhani
DOI: 10.37532/clinicalmicrobiology.2.S3.2-2
Short Communication P.3-3
Physical Control Of Microbial Loads In Fish Product
Author(s): Mayowa Johnson Abioye
DOI: 10.37532/clinicalmicrobiology.2.S3.3-3
Short Communication P.4-4
Combination Treatment of Protease, DNase I, and Antibiotic for Biofilm-Involved Staphylococcus epidermidis Infections
Author(s): Vincent Xin
DOI: 10.37532/clinicalmicrobiology.2.S3.4-4
Short Communication P.5-5
Seroprevalence and genotype profile of hepatitis B virus among antenatal attendees of a tertiary hospital in Nigeria
Author(s): Yahaya Shaibu Usman
DOI: 10.37532/clinicalmicrobiology.2.S3.5-5
Short Communication P.4-4
The use of probiotics as an alternative to address sport-related health concerns.
Author(s): Eudes Anihouvi
DOI: 10.35841/public- health.2.1.4-4
Short Communication P.5-5
Safety and Efficacy of Antiviral Drugs for the Treatment of Patients with SARS-CoV-2 Infection: A Systematic Review and Meta-analyses
Author(s): Mrs Zuleika Aponte Torres
DOI: 10.35841/public- health.2.1.5-5
Short Communication P.6-6
Survey on the nutritional profile of children and adolescents with autism spectrum disorders (ASD) in Europe (Germany and Spain), the United States (EU), and Puerto Rico (PR)
Author(s): Mrs Zuleika Aponte Torres
DOI: 10.35841/public- health.2.1.6-6
Short Communication P.7-7
Public Health Policy Administration and the effect on Americansâ?? Everyday lives
Author(s): Ms Taiwo Majekodunmi
DOI: 10.35841/public- health.2.1.7-7